Reduced Burden for Oncology Patients With Decentralized Visits
Learn how our team helped implement decentralized visits for an oncology study that reduced patient burden and stress on the sites.
Oncology studies often require frequent sample collection visits. Being immunocompromised or weak from treatment poses an additional burden for travel and a rigorous day-to-day schedule for Oncology patients. Additionally, for these types of trials, frequent unscheduled safety visits are necessary but make it difficult for sites and patients to accommodate.
Read how ProPharma Group implemented decentralized trial visits to reduce the burden for patient participation as well as alleviated stress on the sites.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma Group offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma Group’s Compliance and Quality team completed the...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...